AI Insight
A randomized clinical trial at the Icahn School of Medicine at Mount Sinai found that Mindfulness-Oriented Recovery Enhancement (MORE) may alter brain responses to opioid-related cues and natural rewards in people with opioid use disorder. The behavioral therapy, used as a complement to medication treatment, appears to modify neural processing patterns associated with drug craving. The research provides neurobiological evidence for how mindfulness-based interventions may support addiction recovery.
Why it matters
This finding suggests that combining mindfulness therapy with standard medication treatment could enhance outcomes for opioid addiction by targeting the brain's reward processing systems. The research may inform more effective, integrated treatment approaches for the ongoing opioid crisis.
Understand the Science
Mindfulness-Oriented Recovery Enhancement (MORE), a behavioral therapy used alongside medication treatment, may help people with opioid use disorder respond differently to drug-related cues and natural rewards, according to a randomized clinical trial led by researchers at the Icahn School of Medicine at Mount Sinai. The findings offer insight into how MORE may reduce opioid craving and support recovery.
Source: Mindfulness-based therapy may reshape brain responses to opioid cues during addiction treatment